Genomewide linkage scan for opioid dependence and related traits.

Division of Human Genetics, Department of Psychiatry, Yale University School of Medicine, West Haven, CT 06516, USA.
The American Journal of Human Genetics (Impact Factor: 10.99). 06/2006; 78(5):759-69. DOI: 10.1086/503631
Source: PubMed

ABSTRACT Risk of opioid dependence is genetically influenced. We recruited a sample of 393 small nuclear families (including 250 full-sib and 46 half-sib pairs), each with at least one individual with opioid dependence. Subjects underwent a detailed evaluation of substance dependence-related traits. As planned a priori to reduce heterogeneity, we used cluster analytic methods to identify opioid dependence-related symptom clusters, which were shown to be heritable. We then completed a genomewide linkage scan (with 409 markers) for the opioid-dependence diagnosis and for the two cluster-defined phenotypes represented by >250 families: the heavy-opioid-use cluster and the non-opioid-use cluster. Further exploratory analyses were completed for the other cluster-defined phenotypes. The statistically strongest results were seen with the cluster-defined traits. For the heavy-opioid-use cluster, we observed a LOD score of 3.06 on chromosome 17 (empirical pointwise P = .0002) for European American (EA) and African American (AA) subjects combined, and, for the non-opioid-use cluster, we observed a LOD score of 3.46 elsewhere on chromosome 17 (empirical pointwise P = .00002, uncorrected for multiple traits studied) for EA subjects only. We also identified a possible linkage (LOD score 2.43) of opioid dependence with chromosome 2 markers for the AA subjects. These results are an initial step in identifying genes for opioid dependence on the basis of a genomewide investigation (i.e., a study not conditioned on prior physiological candidate-gene hypotheses).


Available from: Marsha Wilcox, Dec 18, 2013
  • [Show abstract] [Hide abstract]
    ABSTRACT: Identifying genetic variation underlying a complex disease is important. Many complex diseases have heterogeneous phenotypes and are products of a variety of genetic and environmental factors acting in concert. Deriving highly heritable quantitative traits of a complex disease can improve the identification of genetic risk of the disease. The most sophisticated methods so far perform unsupervised cluster analysis on phenotypic features; and then a quantitative trait is derived based on each resultant cluster. Heritability is estimated to assess the validity of the derived quantitative traits. However, none of these methods explicitly maximize the heritability of the derived traits. We propose a quadratic optimization approach that directly utilizes heritability as an objective during the derivation of quantitative traits of a disease. This method maximizes an objective function that is formulated by decomposing the traditional maximum likelihood method for estimating heritability of a quantitative trait. We demonstrate the effectiveness of the proposed method on both synthetic data and real-world problems. We apply our algorithm to identify highly heritable traits of complex human-behavior disorders including opioid and cocaine use disorders, and highly heritable traits of dairy cattle that are economically important. Our approach outperforms standard cluster analysis and several previous methods.
    Proceedings of the 19th ACM SIGKDD international conference on Knowledge discovery and data mining; 08/2013
  • [Show abstract] [Hide abstract]
    ABSTRACT: Identifying genetic variations that underlie human disease is very important to advance our understanding of the disease's pathophysiology and promote its personalized treatment. However, many disease phenotypes have complex clinical manifestations and a complicated etiology. Gene finding efforts for complex diseases have had limited success to date. Research results suggest that one way to enhance these efforts is to differentiate subtypes of a complex multifactorial disease phenotype. Existing subtyping methods rely on cluster analysis using only clinical features of a disorder without guidance from genetic data, resulting in subtypes for which genotype association may be limited. In this work, we seek to derive a novel computational method based on multi-objective programming that is capable of clinically categorizing a disease phenotype so as to discover genetically different subtypes. Our approach optimizes two objectives: (1) the cluster-derived subtypes should differ significantly on clinical features; (2) these subtypes can be well separated using candidate genes. This work has been motivated by clinical studies of opioid dependence, a serious, prevalent disorder that is heterogeneous phenotypically. Analyses on a sample of 1,470 European American subjects aggregated from multiple genetic studies of opioid dependence show that the proposed algorithm is superior to existing subtyping methods.
    Bioinformatics and Biomedicine (BIBM), 2012 IEEE International Conference on; 01/2012
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Accurate classification of patients with a complex disease into subtypes has important implications formedicine and healthcare. Using more homogeneous disease subtypes in genetic association analysiswill facilitate the detection of new genetic variants that are not detectible using the non-differentiateddisease phenotype. Subtype differentiation can also improve diagnostic classification, which canin turn inform clinical decision making and treatment matching. Currently, the most sophisticatedmethods for disease subtyping perform cluster analysis using patients¿ clinical features. Withoutguidance from genetic information, the resultant subtypes are likely to be suboptimal and efforts atgenetic association may fail.
    BMC Genetics 06/2014; 15(1):73. DOI:10.1186/1471-2156-15-73 · 2.36 Impact Factor